Literature DB >> 2721545

Transcutaneous absorption of naproxen gel.

F A van den Ouweland1, P C Eenhoorn, Y Tan, F W Gribnau.   

Abstract

The kinetics of naproxen was studied in healthy volunteers after cutaneous application of gels containing 5 and 10% of the drug. Bioavailability was estimated from serum concentration and cumulative urinary metabolite excretion data, both determined up to 96 hours after drug administration. The mean bioavailability after the 10% gel was 1.1% (serum data) and 1.0% (urine data), and after the 5% gel it was 2.1% (serum data) and 1.8% (urine data). Despite the small amount of naproxen absorbed, a potential pharmacological effect, due to cutaneous accumulation of the drug following topical administration, may be suggested from the course of the serum concentration-time curves.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2721545     DOI: 10.1007/BF00609198

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  2 in total

1.  Naproxen kinetics and disease activity in rheumatoid arthritis: a within-patient study.

Authors:  F A Van den Ouweland; F W Gribnau; C A Van Ginneken; Y Tan; L B Van de Putte
Journal:  Clin Pharmacol Ther       Date:  1988-01       Impact factor: 6.875

2.  [The percutaneous absorption of diclofenac].

Authors:  W Riess; K Schmid; L Botta; K Kobayashi; J Moppert; W Schneider; A Sioufi; A Strusberg; M Tomasi
Journal:  Arzneimittelforschung       Date:  1986-07
  2 in total
  5 in total

1.  Synthesis, in vitro skin permeation studies, and PLS-analysis of new naproxen derivatives.

Authors:  H Weber; U Steimer; R Mannhold; G Cruciani
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

2.  Synthesis and in vitro evaluation of aminoacyloxyalkyl esters of 2-(6-methoxy-2-naphthyl)propionic acid as novel naproxen prodrugs for dermal drug delivery.

Authors:  J Rautio; T Nevalainen; H Taipale; J Vepsäläinen; J Gynther; T Pedersen; T Järvinen
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

Review 3.  Clinical pharmacokinetics of naproxen.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

Review 4.  Topical NSAIDs for musculoskeletal conditions. A review of the literature.

Authors:  J H Vaile; P Davis
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

5.  NSAIDs as a Drug Repurposing Strategy for Biofilm Control.

Authors:  Cláudia Leão; Anabela Borges; Manuel Simões
Journal:  Antibiotics (Basel)       Date:  2020-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.